Status:

WITHDRAWN

Virtual Reality as a New Therapeutic Tool for Chronic Pain

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Conditions:

Fibromyalgia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Chronic pain is a major health problem and it has been estimate to account for approximately 40% of all medical visits, costing more than $600 billion annually in the United States alone. Given that p...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • A diagnosis of fibromyalgia according to current diagnostic criteria
  • Aged \> 18 years old
  • Capable of judgement
  • Willing to participate in the study (by signing the informed consent form)
  • Able to follow the study protocol
  • Exclusion criteria
  • Presence of psychosis or major depression with suicidal risk
  • History of alcohol or drug abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, inability to wear head-mounted display
  • Arrythmia, such as atrial fibrillation

Exclusion

    Key Trial Info

    Start Date :

    December 17 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    October 1 2023

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT04108702

    Start Date

    December 17 2019

    End Date

    October 1 2023

    Last Update

    February 13 2023

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.